Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects. MedStar authors:
- Hussaini, Azra
- Kostov, Ivan
Year: 2016
Citation: - Antimicrobial Agents & Chemotherapy. 60(12):7321-7332, 2016 Dec
Department: - PAREXEL Early Phase Clinical Unit
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Bouhired S, Duparc S, Goyal N, Green JA, Hussaini A, Jones SW, Koh GC, Kostov I, Mohamed K, Taylor M, Wolstenholm A
|
|
|
4.
|
Safety of eptifibatide when added to bivalirudin during ST-segment elevation myocardial infarction. MedStar authors:
- Baker, Nevin C
- Escarcega, Ricardo O
- Lipinski, Michael J
- Magalhaes, Marco A
- Torguson, Rebecca
- Waksman, Ron
Year: 2014
Citation: - Cardiovascular Revascularization Medicine. 15(5):278-83, 2014 Jul-Aug.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Baker NC, Escarcega RO, Lipinski MJ, Magalhaes MA, Torguson R, Waksman R
|
|
|
5.
|
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(12):2262-2271, 2019 12.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
|
|
|
6.
|
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
Year: 2014
Citation: - Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
|
|
|
7.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
|
8.
|
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
|
|
|
9.
|
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. MedStar authors:
Citation: - New England Journal of Medicine. 373(8):714-25, 2015 Aug 20.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ackerman P, ALLY-2 Investigators, Dieterich D, Dretler R, Fishbein D, Gathe JC Jr, Henn S, Hinestrosa F, Hughes E, Huynh C, Liu Z, Luetkemeyer A, McDonald C, McPhee F, Mills A, Morgan TR, Noviello S, Overton ET, Ramgopal M, Rashbaum B, Ray G, Ruane PJ, Scarsella A, Sherman KE, Sulkowski MS, Wyles DL, Yin PD, Yozviak J
|
|
|
10.
|
Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting beta-Agonist for Step-Up Therapy in Asthma. MedStar authors:
Year: 2015
Citation: - Annals of the American Thoracic Society. 12(6):798-806, 2015 Jun.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Burden A, Colice G, Dorinsky PM, Grigg J, Guilbert TW, Hillyer EV, Israel E, Martin RJ, Postma DS, Price DB, Roche N, Thomas V, van Aalderen WM, von Ziegenweidt J
|
|
|
11.
|
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. MedStar authors:
Year: 2021
Citation: - Hepatology. 74(6):2952-2964, 2021 12.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Darling JM, Di Bisceglie A, Dong M, Evon DM, Fishbein DA, Fried MW, Hinestrosa F, Horne PM, Khalili M, Kixmiller S, Lok AS, Michael L, Moon JS, Morelli G, Muir AJ, Nelson DR, Pearlman B, Peter J, PRIORITIZE Study Team, Rajender Reddy K, Segal JB, Sherman KE, Shiffman ML, Sloan A, Stewart PW, Sulkowski MS, Vainorius M, Wadsworth S
|
|
|
12.
|
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. MedStar authors:
Citation: - Gut. 63(1):161-9, 2014 Jan.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Gastroenterology
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
All authors: - Abdalla A, Ahlenstiel G, Dahari H, Doo E, Edlich B, Feld JJ, Gara N, Ghany MG, Guedj J, Han H, Heller T, Hogdal L, Hoofnagle JH, Koh C, Liang TJ, Noureddin M, Park SH, Park YJ, Perelson AS, Rehermann B, Rotman Y, Sarkar S, Thomas E, Titerence R, Witthaus M
|
|
|
13.
|
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(11):2108-2116, 2019 11.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
|
|
|
14.
|
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
Year: 2020
Citation: - Diabetes Care. 43(5):940-947, 2020 05.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
|
